This live web event has ended. Thank you for attending.
0 of 2 Sessions Available
-
OCT15October 15, 2019Tue 7:00 PM EDT 1HClosed
-
Farzana Perwad, MD
-
-
NOV21November 21, 2019Thu 4:00 PM EST 1HClosed
-
Suzanne Jan De Beur, MD
-
Contributors
-
Suzanne Jan De Beur, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine Baltimore, MD
Suzanne Jan De Beur, MD is Associate Professor of Medicine at the Johns Hopkins University School of Medicine and Director of the Clinical Research Units of the Johns Hopkins Institute for Clinical and Translational Research. She received her BA and her medical doctorate from Cornell University. She completed the Osler Medical Residency at the Johns Hopkins Hospital and her fellowship in endocrinology and metabolism at the Johns Hopkins University School of Medicine.
As a physician-scientist and practicing endocrinologist, Dr. Jan de Beur’s clinical and research work focuses on understanding rare and metabolic bone diseases at the basic level and translating these observations to the bedside. Specifically, her research interests include understanding the physiology of FGF23 and the molecular basis of disorders of phosphate homeostasis, emerging treatments for rare bone diseases, and the genetic basis of parathyroid hormone resistance syndromes. Dr. Jan de Beur has authored numerous peer-reviewed publications, reviews, and book chapters in high-impact journals, including New England Journal of Medicine, Journal of the American Medical Association, Journal of Clinical Investigation, and The Lancet. -
Farzana Perwad, MD
Associate Professor
Chief, Division of Nephrology
Director, Pediatric Nephrology Fellowship Program
Director, Scholarship Oversight Committee
University of California San Francisco
Children's Renal Center
San Francisco, CA
Farzana Perwad, MD is an Associate Professor in the Department of Pediatrics at the University of California San Francisco (UCSF). She is the Division Chief of Pediatric Nephrology at UCSF and her research interests are in the field of bone and mineral disorders related to kidney disease. Specifically, Dr. Perwad’s research focuses on the regulation of vitamin D and phosphorus homeostasis by fibroblast growth factor 23 (FGF23). Her research projects include investigating the pathophysiology of X-linked hypophosphatemia (XLH) in mouse models of XLH, and the molecular mechanisms of action of FGF23 in the kidney.